These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3038257)

  • 41. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities).
    Woo KS; Norris RM; Nicholls G
    Am J Cardiol; 1995 May; 75(14):967-8. PubMed ID: 7733017
    [No Abstract]   [Full Text] [Related]  

  • 42. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme.
    Semple PF; Herd GW
    N Engl J Med; 1986 Jan; 314(1):61. PubMed ID: 2999601
    [No Abstract]   [Full Text] [Related]  

  • 43. Interaction of noscapine with the bradykinin mediation of the cough response.
    Ebrahimi SA; Zareie MR; Rostami P; Mahmoudian M
    Acta Physiol Hung; 2003; 90(2):147-55. PubMed ID: 12903913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.
    Inman WH; Rawson NS; Wilton LV; Pearce GL; Speirs CJ
    BMJ; 1988 Oct; 297(6652):826-9. PubMed ID: 2846101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.
    Rumboldt Z; Marinković M; Drinovec J
    Int J Clin Pharmacol Res; 1988; 8(3):181-8. PubMed ID: 2841251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bronchial reactivity and cough due to ACE inhibitors].
    Canessa PA; Torraca A
    Medicina (Firenze); 1990; 10(3):296-8. PubMed ID: 2079884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Captopril: 4 years of post marketing surveillance of all patients in New Zealand.
    Edwards IR; Coulter DM; Beasley DM; MacIntosh D
    Br J Clin Pharmacol; 1987 May; 23(5):529-36. PubMed ID: 3297125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides.
    Furness PN; Goodfield MJ; MacLennan KA; Stevens A; Millard LG
    J Clin Pathol; 1986 Aug; 39(8):902-7. PubMed ID: 3018050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice.
    Cooper WD; Sheldon D; Brown D; Kimber GR; Isitt VL; Currie WJ
    J R Coll Gen Pract; 1987 Aug; 37(301):346-9. PubMed ID: 2834550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of cough during angiotensin-converting enzyme inhibitor therapy.
    Goldszer RC; Lilly LS; Solomon HS
    Am J Med; 1988 Dec; 85(6):887. PubMed ID: 2848417
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of dose adjustment on enalapril-induced cough and the response to inhaled capsaicin.
    Yeo WW; Higgins KS; Foster G; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1995 Mar; 39(3):271-6. PubMed ID: 7619668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postmarketing surveillance of captopril for hypertension.
    Chalmers D; Whitehead A; Lawson DH
    Br J Clin Pharmacol; 1992 Sep; 34(3):215-23. PubMed ID: 1389946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiooedema and urticaria with angiotensin converting enzyme inhibitors.
    Pillans PI; Coulter DM; Black P
    Eur J Clin Pharmacol; 1996; 51(2):123-6. PubMed ID: 8911875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Respiratory complications of inhibitors of conversion enzyme].
    Witchitz S; Beaufils M; Liote H; Petroff C
    Presse Med; 1989 Apr; 18(17):896. PubMed ID: 2544868
    [No Abstract]   [Full Text] [Related]  

  • 55. Cough is common in children prescribed converting enzyme inhibitors.
    von Vigier RO; Mozzettini S; Truttmann AC; Meregalli P; Ramelli GP; Bianchetti MG
    Nephron; 2000 Jan; 84(1):98. PubMed ID: 10644922
    [No Abstract]   [Full Text] [Related]  

  • 56. Angiotensin converting enzyme inhibitors and cough--a north Indian study.
    Singh NP; Uppal M; Anuradha S; Agarwal A; Rizvi SN
    J Assoc Physicians India; 1998 May; 46(5):448-51. PubMed ID: 11273288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zinc metabolism in patients treated with captopril versus enalapril.
    Golik A; Modai D; Averbukh Z; Sheffy M; Shamis A; Cohen N; Shaked U; Dolev E
    Metabolism; 1990 Jul; 39(7):665-7. PubMed ID: 2195291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity.
    Hagley MT; Benak RL; Hulisz DT
    Ann Pharmacother; 1992 Jun; 26(6):780-1. PubMed ID: 1611160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.
    Testa MA; Anderson RB; Nackley JF; Hollenberg NK
    N Engl J Med; 1993 Apr; 328(13):907-13. PubMed ID: 8446137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of captopril and enalapril in patients with severe chronic heart failure.
    Packer M; Lee WH; Yushak M; Medina N
    N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.